news_image.jpg

New drug approved by FDA for treating growth hormone deficiency

04 Sep 2020



The new drug, somapacitan, has been approved by the US Food and Drug Administration as a replacement growth hormone in adults with growth hormone deficiency and is the first drug that can be administered weekly, rather than daily.

Medscape



Issue 48 - Summer 2020 - Thyroid disease in children

Latest Newsletter

Issue 48 - Summer 2020 - Thyroid disease in children

Issue 48 - Summer 2020 - Thyroid disease in children

Newsletter Archive

Previous newsletters can be viewed and downloaded from the archive.

Newsletter Archive